AT2220 (duvoglustat)

duvoglustat · Amicus Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT2220 (duvoglustat), covering 2018-08-17 to 2018-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease [Phase 2]